The first Royalty Pharma plc trade was made in Q2 2021.
Since then Jim Simons bought shares three more times and sold shares on six occasions. The investor completely sold their stake between Q2 2023 and Q4 2023.
Avg closing price
Price range
Sold -483 Thousand shares
Q4 2023
Avg closing price
$27.48
Price range
$26.21
-
$29.22
Sold 37.3% shares (-288 Thousand shares)
Q3 2023
Avg closing price
$29.70
Price range
$26.26
-
$31.38
Sold 40.8% shares (-530 Thousand shares)
Q2 2023
Avg closing price
$33.87
Price range
$29.60
-
$36.56
Increased shares by 49.7% (+432 Thousand shares)
Q1 2023
Avg closing price
$37.08
Price range
$32.77
-
$39.40
New holding (+869 Thousand shares)
Q4 2022
Avg closing price
$41.74
Price range
$39.17
-
$44.04
Sold -184 Thousand shares
Q2 2022
Avg closing price
$41.01
Price range
$37.53
-
$44.22
Sold 77.0% shares (-615 Thousand shares)
Q1 2022
Avg closing price
$39.27
Price range
$37.46
-
$42.44
Increased shares by 2.0% (+15.5 Thousand shares)
Q4 2021